Related Experiment Video
Updated: Oct 17, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer
J Kurebayashi1, T Otsuki, H Kunisue
1Department of Breast and Thyroid Surgery, Kawasaki Medical School, Okayama, Japan. kure@med.kawasaki-m.ac.jp
Abstract:
Recent studies have indicated that a complex machinery of transactivation of target genes by estrogen or antiestrogen through estrogen receptor (ER) exists. However, the substantial roles of ER-beta, coactivators, and corepressors in the development and progression of breast cancer remain to be elucidated. To obtain some clue to these roles, we screened the expression levels of ER-alpha, ER-beta, coactivators (SRC-1, TIF2, AIB1, CBP, and P/CAF) and corepressors (N-CoR and SMRT) in 6 normal mammary glands, 6 intraductal carcinomas, 22 invasive ductal carcinomas, and 7 breast cancer cell lines using a multiplex reverse transcription-PCR. ER-alpha mRNA expression levels significantly correlated with ER-alpha protein levels measured by enzyme immunoassay in the breast cancer tissues and cell lines. A significant correlation of expression levels was observed between ER-alpha and TIF2, AIB1, P/CAF, and N-CoR, and between ER-beta and AIB1 and CBP in the tissue samples. A significant correlation was also observed between ER-alpha and ER-beta and between ER-beta and CBP in the cell lines. The expression levels of ER-alpha, TIF2, and CBP were significantly higher in the intraductal carcinomas than those in the normal mammary glands. In addition, the expression levels of ER-alpha and N-CoR were significantly higher in the intraductal carcinomas than those in the invasive ductal carcinomas. These findings suggest a positive correlation of expression levels among ER-alpha and cofactors and among ER-beta and cofactors, an up-regulation of expression levels of ER-alpha and cofactors during the development of intraductal carcinomas from normal mammary glands, and a decrease in their expression levels during the progression of breast cancer.
Insights
Estrogen receptor (ER)-alpha and cofactors are upregulated during early breast cancer development. Their expression decreases as breast cancer progresses, suggesting roles in tumor development and progression.
Area of Science:
- Molecular Biology
- Oncology
- Gene Expression Analysis
Background:
- Estrogen receptor (ER) signaling is crucial in breast cancer, involving complex interactions with coactivators and corepressors.
- The specific roles of ER-beta, coactivators, and corepressors in breast cancer development and progression require further elucidation.
Purpose of the Study:
- To investigate the expression levels of ER-alpha, ER-beta, coactivators, and corepressors in normal mammary glands, intraductal carcinomas, invasive ductal carcinomas, and breast cancer cell lines.
- To explore potential correlations between ERs, coactivators, and corepressors in breast cancer tissues and cell lines.
Main Methods:
- Multiplex reverse transcription-PCR was used to screen expression levels of ER-alpha, ER-beta, coactivators (SRC-1, TIF2, AIB1, CBP, P/CAF), and corepressors (N-CoR, SMRT).
- Enzyme immunoassay was employed to measure ER-alpha protein levels for correlation analysis with mRNA expression.
Main Results:
- ER-alpha mRNA expression strongly correlated with ER-alpha protein levels.
- Significant correlations were found between ER-alpha and cofactors (TIF2, AIB1, P/CAF, N-CoR), and between ER-beta and cofactors (AIB1, CBP).
- ER-alpha, TIF2, and CBP were upregulated in intraductal carcinomas compared to normal glands, while ER-alpha and N-CoR were higher in intraductal than invasive carcinomas.
Conclusions:
- Findings suggest a positive correlation between ERs and cofactors, with ER-alpha and cofactors upregulated during early breast cancer development (intraductal carcinoma).
- A decrease in ER-alpha and cofactor expression levels during breast cancer progression from intraductal to invasive stages was observed.
- These cofactors may play significant roles in breast cancer development and progression, warranting further investigation.
Related Concept Videos
Co-activators and Co-repressors
Co-activators and Co-repressors
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Cell Specific Gene Expression
RNA Polymerase II Accessory Proteins
Prokaryotic Transcriptional Activators and Repressors
Transcription of prokaryotic...
